Epidemiology Series Forecast Report on Erectile Dysfunction in 29 Major Markets
Erectile dysfunction, also known as ED and impotence, is defined as the frequent inability to achieve or maintain an erection sufficient for sexual activity to take place.
This report provides the current prevalent population for Erectile Dysfunction across 29 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Netherlands, Portugal, Switzerland, Croatia, Poland, Romania, Russia, Norway, Sweden, Greece, Turkey, Saudi Arabia, Egypt, China, Japan, South Korea, India, Australia, South Africa, Brazil, Mexico, Argentina) split 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team , several of the main symptoms and co-morbidities of Erectile Dysfunction have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Erectile Dysfunction disease include:
• Chronic heart disease
• Hypertension
• Diabetes
• BPH
• Anaemia
• Depression
• Loss of libido
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
• Able to quantify patient populations in global Erectile Dysfunction market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the prevalence of the subdivided types of Erectile Dysfunction and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on Erectile Dysfunction prevalent population.
• Identify sub-populations within Erectile Dysfunction which require treatment.
• Gain an understanding of the specific markets that have the largest number of Erectile Dysfunction patients.
• Introduction
• Cause of the Disease
• Risk Factors & Prevention
• Diagnosis of the Disease
• Variation by Geography/Ethnicity
• Disease Prognosis & Clinical Course
• Key comorbid conditions/Features associated with the disease
• Methodology for quantification of patient numbers
• Top-line prevalence for Erectile Dysfunction
• Features of Erectile Dysfunction patients
o Comorbid conditions of ED patients
• Abbreviations used in the report
• Other Black Swan Analysis Publications
• Black Swan Analysis Online Patient-Based Databases
• Patient-Based Offering
• Online Pricing Data and Platforms
• References
• Appendix
• IIEF-5 questionnaire
• Prevalence of Erectile Dysfunction, malesl (000s)
• Severity of ED, males (000s)
• Smoking status of ED patients, males (000s)
• Diagnosed with enlarged prostate, males (000s)
• ED patients with diabetes, males (000s)
• ED patients with depression, males (000s)
• ED patients with hypertension, males (000s)
• Cardiovascular disease, males (000s)
• ED patients that are overweight (BMI ≥ 25), males (000s)
• ED patients that are seeking treatment, males (000s)
• Abbreviations and Acronyms used in the report
• USA Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Canada Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• France Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Germany Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Italy Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Spain Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• UK Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Netherlands Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Portugal Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Switzerland Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Croatia Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Poland Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Romania Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Russia Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Norway Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Sweden Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Greece Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Turkey Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Saudi Arabia Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Egypt Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• China Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Japan Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• South Korea Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• India Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Australia Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• South Africa Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Brazil Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Mexico Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
• Argentina Prevalence of Erectile Dysfunction by 5-yr age cohort, males (000s)
+1 888 709 8757
Chat With Us